Gilead Sciences, Inc. (NASDAQ: GILD) reported Q1 EPS of $0.91, $0.03 worse than the analyst estimate of $0.94. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.2 billion.

For earnings history and earnings-related data on Gilead Sciences, Inc. (GILD) click here.

Earnings Hot Earnings